Streetbeat News

Analyst Ratings

BLK

Goldman Sachs analyst Alexander Blostein has maintained a Buy rating on BlackRock Finance and raised the price target from $960 to $1040.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 4:51 pm

APAM

Goldman Sachs analyst Alexander Blostein maintains a Sell rating on Artisan Partners Asset Management (NYSE:APAM) and lowers the price target from $40 to $39.5.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 4:50 pm

AB

Goldman Sachs analyst Alexander Blostein has maintained a Buy rating on AllianceBernstein Holding (NYSE:AB) and raised the price target from $40.75 to $41.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 4:48 pm

F

Recent options activity for Ford Motor (NYSE:F) shows a bearish sentiment among large investors, with 66% of trades being bearish. The options target a price range of $9.0 to $12.0. Analysts have mixed ratings, with price targets ranging from $9 to $16.

Portfolio Pulse from Benzinga Insights

October 03, 2024 | 4:47 pm

FANG

Benchmark analyst Subash Chandra maintains a Buy rating on Diamondback Energy (NASDAQ:FANG) and raises the price target from $154 to $195.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 4:47 pm

HUM

Piper Sandler has downgraded Humana from Overweight to Neutral and reduced its price target from $392 to $274.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 4:43 pm

INTC

Deutsche Bank analyst Ross Seymore maintains a Hold rating on Intel (NASDAQ:INTC) and lowers the price target from $27 to $25.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 4:40 pm

HUM

Deutsche Bank analyst George Hill maintains a Hold rating on Humana (NYSE:HUM) and lowers the price target from $349 to $250.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 4:32 pm

SBUX

The article discusses recent options trading activity for Starbucks (NASDAQ:SBUX), highlighting a bullish sentiment among traders. Despite a slight decrease in stock price, analysts have set varied price targets, with some upgrading and others downgrading their ratings. The options market shows significant interest in a price range of $85 to $105.

Portfolio Pulse from Benzinga Insights

October 03, 2024 | 4:20 pm

PFE

The article discusses recent options trading trends for Pfizer (NYSE:PFE), highlighting a balanced sentiment among traders with significant call and put options activity. The price target for Pfizer is between $28.0 and $32.0, with a consensus analyst target of $45.0. The stock is currently trading at $28.34, down 0.93%.

Portfolio Pulse from Benzinga Insights

October 03, 2024 | 4:20 pm